Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic and Diagnostic Added Value of Medical Imaging in Staging and Treatment Planning of Gynecological Cancer (PRODIGYN)

NCT05855941 is registered in ClinicalTrials.gov with Region Västerbotten as lead sponsor.

NCT NCT05855941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05855941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic and Diagnostic Added Value of Medical Imaging in Staging and Treatment Planning of Gynecological Cancer (PRODIGYN)
Lead sponsor
Region Västerbotten
Phase
Observational
Overall status
Recruiting
Start date
May 23, 2023
Completion date
May 31, 2032
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervix cancer, endometrial cancer, epithelial ovarian cancer